Parvilla Investissements – 42 av. Montaigne 75008 Paris

Venture Funds / Life Sciences

Sofinnova is one of the
fore-front GPs
in the Life Sciences space

Fund SOFINNOVA VIII Fund SOFINNOVA
CROSS OVER
Fund SOFINNOVA IX Fund SOFINNOVA MD START
Fund SOFINNOVA X
Commitment date : 09/06/2016 Commitment date : 23/10/2017 Commitment date : 12/07/2018 Commitment date : 19/10/2019 Commitment date : 20/05/2021
Pharma fund Cross over fund Pharma fund Early stage MedTech Pharma fund
Fully Invested Investing Investing Investing Investing

Alven Fund

Activity : European digital and
technology
Commitment date :
30/11/2016
Investing

Deep Tech & digital in
Europe

Fonds Elaia Delta Fonds Elaia Alpha 2
Commitment Date: 06/06/2016 Commitment Date: 03/03/2021
Investing Investing

LSP is one of the most established GPs in Life Sciences

Fund LSP HEF 2 Fund LSP 6 Fund LSP 7
Commitment date : 01/12/2017 Commitment date : 10/10/2018 Commitment date : 29/06/2021
Medtech only Pharma fund Pharma fund
Investing Investing Investing

Health for Life Capital
Fund II

Activity : Pharma fund with a
focus on microbiom. Invests in
Europe but also in the USA.
Commitment date : 08/03/2019 Investing

IQ Growth

Activity  : IQ Capital is a well established VC based in Cambridge

Fund dedicated to cross-over.

Commitment date : 21/01/2020 Investing